Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Alterations in the common fragile site gene Parkin in ovarian and other cancers

Abstract

The cloning and characterization of the common fragile site (CFS) FRA6E (6q26) identified Parkin, the gene involved in the pathogenesis of many cases of juvenile, early-onset and, rarely, late-onset Parkinson's disease, as the third large gene to be localized within a large CFS. Initial analyses of Parkin indicated that in addition to playing a role in Parkinson's disease, it might also be involved in the development and/or progression of ovarian cancer. These analyses also indicated striking similarities among the large CFS-locus genes: fragile histidine triad gene (FHIT; 3p14.2), WW domain-containing oxidoreductase gene (WWOX; 16q23), and Parkin (6q26). Analyses of FHIT and WWOX in a variety of different cancer types have identified the presence of alternative transcripts with whole exon deletions. Interestingly, various whole exon duplications and deletions have been identified for Parkin in juvenile and early-onset Parkinson's patients. Therefore, we performed mutational/exon rearrangement analysis of Parkin in ovarian cancer cell lines and primary tumors. Four (66.7%) cell lines and four (18.2%) primary tumors were identified as being heterozygous for the duplication or deletion of a Parkin exon. Additionally, three of 23 (13.0%) nonovarian tumor-derived cell lines were also identified as having a duplication or deletion of one or more Parkin exons. Analysis of Parkin protein expression with antibodies revealed that most of the ovarian cancer cell lines and primary tumors had diminished or absent Parkin expression. While functional analyses have not yet been performed for Parkin, these data suggest that like FHIT and WWOX, Parkin may represent a tumor suppressor gene.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Arlt MF, Miller DE, Beer DG and Glover TW . (2002). Genes Chromosomes Cancer, 33, 82–92.

  • Becker NA, Thorland EC, Denison SR, Phillips LA and Smith DI . (2002). Oncogene, 21, 8713–8722.

  • Bednarek A ., Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ and Aldaz CM . (2001). Cancer Res., 61, 8068–8073.

  • Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA and Aldaz CM . (2000). Cancer Res., 60, 2140–2145.

  • Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia, Picchio MC, Alder H, Godwin AK and Croce CM . (2003). Proc. Natl. Acad. Sci. USA, 100, 5956–5961.

  • Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW and LeBeau MM . (2002). Cancer Res., 62, 3477–3484.

  • Darios F, Corti O, Lücking CB, Hampe C, Muriel MP, Abbas N and Gu WJ . (2003). Hum. Mol. Genet., 12, 517–526.

  • Denison SR, Callahan G, Becker NA, Phillips LA and Smith DI . (2003). Genes Chromosomes Cancer, 38, 40–52.

  • Druck T, Berk L and Huebner K . (1998). Oncol. Res., 10, 341–345.

  • Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM and Huebner K . (1997). Cancer Res., 57, 504–512.

  • Feany MB and Pallanck LJ . (2003). Neuron, 38, 13–16.

  • Gamma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nahashima M, Bennett WP and Harris CC . (1997). Cancer Res., 57, 1435–1437.

  • Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Konda T, Kuzuhara S, Naamura S, Shimizu M and Mizuno Y . (1998). Ann. Neurol., 4, 935–941.

  • Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O, Schwinger E, Vieregge P, Lang AE, Breakefiend XO, Ozelius LJ, Pramstaller PP and Klein C . (2001). Hum. Mol. Genet., 10, 1649–1656.

  • Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meijia-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S and Klein C . (2002). Neurology, 58, 1239–1246.

  • Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L and Kerem B . (2002). Cancer Cell, 1, 89–97.

  • Hoenicka J, Vidal L, Morales B, Ampuero I, Jimenez-Jimenez FJ, Berciano J, del Ser T, Jimenez Z, Ruiz PG and de Yebenes JG . (2002). Arch. Neurol., 59, 966–970.

  • Horowitz JM, Vernace VV, Myers J, Stachowiak MK, Hanlon DW, Fraley GS and Torres G . (2001). J. Chem. Neuroanat., 21, 75–93.

  • Huebner K, Garrison PN, Barnes LD and Croce CM . (1998). Ann. Rev. Genet., 32, 7–31.

  • Huynh DP, Scoles DR, Ho TH, Del Bigio MR and Pulst SM . (2000). Ann. Neurol., 48, 737–744.

  • Imai Y, Soda M and Takahashi R . (2000). J. Biol. Chem., 275, 35661–35664.

  • Ishii H, Damon KR, Vecchione A, Gong LY, Baffa R, Huebner K and Croce CM . (2001). JAMA, 286, 2441–2449.

  • Kahns S, Lykkebo S, Jakobsen LD, Nielson MS and Jensen PH . (2002). J. Biol. Chem., 8, 15303–15308.

  • Kann M, Jacobs H, Mohrmann K, Schumacher K, Hedrich K, Garrels J, Wiegers K, Schwinger E, Pramstaller PP, Breakefield XO, Ozelius LJ, Vieregge P and Klein C . (2002). Ann. Neurol., 51, 621–625.

  • Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizumo Y and Shimizu N . (1998). Nature, 392, 605–608.

  • Knudson AG . (2001). Nat. Rev. Cancer, 1, 157–162.

  • Krummel KA, Denison SR, Calhoun E, Phillips LA and Smith DI . (2002). Genes Chromosomes Cancer, 34, 154–167.

  • Krummel KA, Roberts LR, Kawakami M, Glover TW and Smith DI . (2000). Genomics, 69, 37–46.

  • Le Beau MM, Drabkin H, Glover TW, Gemmill R, Rassool FV, McKeithan TW and Smith DI . (1998). Genes Chromosomes Cancer, 21, 281–289.

  • Lücking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, Agid Y and Brice A . (2000). N. Engl. J. Med., 342, 1560–1567.

  • Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E and Richards RI . (2000). Cancer Res., 60, 1683–1689.

  • Nichols WC, Pankratz N, Uniacke SK, Pauciulo MW, Halter C, Rudolph A, Conneally PM and Foroud T . (2002). J. Med. Genet., 39, 489–492.

  • Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K . (1996). Cell, 84, 587–597.

  • Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ and Watson JE . (2000). Cancer Res., 60, 1690–1697.

  • Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J and Cookson MR . (2002). Neuron, 36, 1007–1019.

  • Roz L, Gramegna M, Ishii H, Croce CM and Sozzi G . (2002). Proc. Natl. Acad. Sci. USA, 99, 3615–3620.

  • Shiraishi T, Druck T, Mimori K, Flomenberg J, Berk L, Alder H, Miller W, Huebner K and Croce CM . (2001). Proc. Natl. Acad. Sci. USA, 98, 5722–5727.

  • Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM and Huebner K . (1997). Proc. Natl. Acad. Sci. USA, 94, 13771–13776.

  • Smith DI, Huang H and Wang L . (1998). Int. J. Oncol., 12, 187–196.

  • Staropoli JF, McDermott C, Marinat C, Schulman B, Demireva E and Abeliovich A . (2003). Neuron, 37, 735–749.

  • Sutherland GR, Baker E and Richards RI . (1998). Trends Genet., 14, 501–506.

  • Tanaka K, Suzuki T, Chiba T, Shimura H, Hattori N and Mizuno Y . (2001). J. Mol. Med., 79, 482–494.

  • Verma R and Babu A (eds). (1995). Human Chromosomes: Principles and Techniques, 2nd edn. McGraw-Hill: New York.

    Google Scholar 

  • West A, Periquet M, Lincoln S, Lucking CB, Nicholl D, Bonifati V, Rawal N, Gasser T, Lohmann E, Deleuze JF, Maraganore D, Levey A, Wood N, Durr A, Hardy J, Brice A and Farrer M . (2002). Am. J. Med. Genet., 114, 584–591.

  • Zhang Y, Gao J, Chung KK, Huang H, Dawson VL and Dawson TM . (2000). Proc. Natl. Acad. Sci. USA, 97, 13354–13359.

Download references

Acknowledgements

This work was supported by NIH Grant CA48031, Department of Defense Grant DAMD 17-99-1-9504, by the Minnesota Ovarian Cancer Alliance (MOCA) (all to DIS), and by the Deutsche Forschungsgemeinschaft Kl-1134/2-1 and 2-2 (to CK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David I Smith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denison, S., Wang, F., Becker, N. et al. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 22, 8370–8378 (2003). https://doi.org/10.1038/sj.onc.1207072

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207072

Keywords

This article is cited by

Search

Quick links